Pharmaceutical

$34.9 Million Verdict in Trademark Dispute Shakes Up Pharmaceutical Industry: ImprimisRx Wins Case Over Compounded Eye Drops

by

San Diego, CA — A federal jury awarded $34.9 million to a pharmaceutical company following a heated four-day trial concerning trademark disputes over specialized post-surgical eyedrops. The verdict, handed down on Wednesday in a San Diego courtroom, addressed allegations of trademark infringement involving compounded ophthalmic medications. These medications are custom mixes specifically prepared to meet the unique needs of individual patients, particularly beneficial in eye care treatments. Carlsbad-based ImprimisRx LLC, which brought the lawsuit, claimed they pioneered the market with these unique formulations, each safeguarded under its own trademark. ImprimisRx LLC argued that competitor OSRX … Read more

Susan Sharko Honored Among “America’s Top 200 Lawyers” by Forbes for Excellence in Pharmaceutical and Medical Device Litigation

by

In a recent acknowledgment of legal prowess, Susan Sharko, a distinguished partner in product liability and mass torts, has earned herself a position on Forbes’ first ever compilation of “America’s Top 200 Lawyers.” This prestigious listing was unveiled as a recognition of lawyers across the nation who not only excel in their legal practice but also lead and innovate within their respective fields. The announcement comes as a testament to Sharko’s reputation as a leading figure in the complex sectors of pharmaceutical and medical device litigation. Her practice encompasses a broad array of responsibilities which … Read more

Legal Luminary Daniel Nigh Ascends to Key Roles in Major Pharmaceutical Litigations, Shaping Justice in Groundbreaking Health Suits

by

Washington D.C. — Daniel Nigh, a prominent attorney based in the nation’s capital, has distinguished himself as much more than a legal scholar. Founding partner of Nigh Goldenberg Raso & Vaughn, Nigh brings an extensive portfolio that spans various high-stakes arenas, including pharmaceutical and medical device litigations, as well as cryptocurrency exchange bankruptcies and mass torts. Nigh’s expertise has not gone unnoticed. His adept handling of complex litigation has precipitated his appointments to several leadership roles in mass tort lawsuits that influence both the legal landscape and public health. Most notably, he presently serves as … Read more

Stephen Huffaker Joins DLA Piper’s Austin Team, Bolstering Expertise in Pharmaceutical and Medical Device Litigation

by

Austin, TX – Stephen Huffaker has taken a significant step in his legal career by joining DLA Piper, stepping into a role as a partner within the firm’s specialized practice area focusing on product liability, mass torts, and class actions. This move, which was officially announced on September 10, places Huffaker in a key position within one of the most respected law firms in the city. At DLA Piper, Huffaker will leverage his considerable expertise in the pharmaceutical and medical device sectors. His work largely revolves around strategy coordination in mass tort cases, aiming for … Read more